SOLICITATION NOTICE
65 -- Midazolam as a Medical Countermeasure for Organophosphorus (OP) Compound Exposure - Pre-Solicitation Notice for Midazolam as a Medical Countermeasure for Organophosphorus (OP) Compound Exposure
- Notice Date
- 11/16/2012
- Notice Type
- Presolicitation
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- RFP-13-100-SOL-00002
- Point of Contact
- Susan Cortes-Shrank, Phone: 3016967285, Jason Bell, Phone: 202-260-1457
- E-Mail Address
-
susan.cortes-shrank@hhs.gov, jason.bell@hhs.gov
(susan.cortes-shrank@hhs.gov, jason.bell@hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Pre-Solicitation Notice for Midazolam as a Medical Countermeasure for Organophosphorus (OP) Compound Exposure The Department of Health and Human Services (HHS) has the responsibility of maintaining a definitive supply of medical countermeasures - or the forward deployment of the same - for use in national medical emergencies declared by the Secretary of HHS. HHS has a requirement to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological, radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for anticonvulsant products to treat individuals with nerve agent-induced seizures resulting from chemical weapons agents and organophosphorous (OP) compounds. HHS through the Office of the Assistant Secretary of Preparedness and Response (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA) contemplates award of a Firm Fixed Price contract under Project Bioshield for purchase of product with optional Cost Plus Fixed Fee CLINS for product development. SEE PRE-SOLICITATION NOTICE FOR MORE INFORMATION
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/RFP-13-100-SOL-00002/listing.html)
- Record
- SN02933128-W 20121118/121116235249-53a1b9218d4e99274bdd82bcbaf18ce0 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |